AAOI
Applied Optoelectronics, Inc.
800G / 1.6T Optical Transceivers
$157.55
13 May 2026 · 52W $15.06–$191.87 · Mkt cap ~$12.6B
Q1 2026: $151.1M (+51% YoY) · Q2 guide: $180–198M · FY26 guide: >$1.1B
◆ Watch
Entry zone: $120–140 (after Q2 print 6 Aug validates H2 ramp)
The variant perception: market prices AAOI as a speculative, pre-profitability optical transceiver company with dangerous concentration risk. The counter: AAOI is the only company to have shipped 800G transceivers to a hyperscaler in volume, with US-domiciled manufacturing, at a run rate that implies FY26 revenue >$1.1B (+140% YoY). Q1 data centre revenue was $81.4M (+154% YoY) — not a rumour, not a guide, a reported result. At full Texas fab capacity (650K units/month), the addressable revenue envelope exceeds $10B annually. The market hasn't priced the scale-up because it hasn't happened yet. Watch $120–140 as a post-Q2 entry if the ramp validates on 6 Aug.
Q1 2026 Revenue
$151.1M
+51% YoY · DC $81.4M (+154%)
Q2 2026 Guide
$180–198M
Non-GAAP GM 29–30%
FY26 Guide
>$1.1B
>$140M non-GAAP op income
Gross Margin Q1
29.1%
Target 35% YE26 · 40%+ 2027
Cash
$449.4M
After $382.4M equity raise
GAAP Status
Loss-making
Q2 = first non-GAAP profit est.
Insider Selling
$29.6M
90 days — consistent seller pattern
Key Gate
6 Aug
Q2 print — ramp validation
Thesis Durability
B+
First 800G optical transceiver vendor to ship in volume to a hyperscaler — confirmed, not speculative. Data centre revenue +154% YoY in Q1. FY26 revenue guide >$1.1B (141% YoY) — a real forward commitment, heavily back-weighted to H2 2026.
Capacity ramp trajectory (management-guided): Q1 exit 100K units/month → Q2 exit ~150K → end-2026 >650K (30% from Texas) → end-2027 >930K (>50% from Texas). The 100K units/month at Q1 exit represents revenue recognised in Q3 (1-2 quarter lag between capacity and revenue). 1.6T runs on the same production lines as 800G — no new factory required, enabling concurrent ramp.5
Product mix shift is the revenue story: In Q1, 800G was only $4.6M (5.6% of DC revenue) and 1.6T was 0%. Over the next 12-18 months, management guides toward 46% of revenue from 800G and 35% from 1.6T — two categories currently representing <6% of revenue expanding to ~80%.5 Added one new 1.6T hyperscaler and two 800G customers in Q1.
Vertical InP moat: InP laser manufacturing is the single most constrained component in the optical transceiver supply chain. AAOI has made lasers in-house for over 30 years — competitors face 21–24 month lead times for InP capacity additions; AAOI has <1 year of inventory on hand and is actively qualifying additional production equipment. This vertical integration is what customers specifically cite when selecting AAOI over Asian alternatives in the current supply environment.5 ELS/CPO opportunity: AAOI plans to expand Texas laser fabrication capacity +350% by end-2027 to serve External Laser Source (ELS) demand from co-packaged optics (CPO) deployments — a separate demand vector on top of the transceiver ramp.
The durability question is execution — whether the H2 2026 ramp and InP supply can track management's guidance — not thesis validity.
Capacity ramp trajectory (management-guided): Q1 exit 100K units/month → Q2 exit ~150K → end-2026 >650K (30% from Texas) → end-2027 >930K (>50% from Texas). The 100K units/month at Q1 exit represents revenue recognised in Q3 (1-2 quarter lag between capacity and revenue). 1.6T runs on the same production lines as 800G — no new factory required, enabling concurrent ramp.5
Product mix shift is the revenue story: In Q1, 800G was only $4.6M (5.6% of DC revenue) and 1.6T was 0%. Over the next 12-18 months, management guides toward 46% of revenue from 800G and 35% from 1.6T — two categories currently representing <6% of revenue expanding to ~80%.5 Added one new 1.6T hyperscaler and two 800G customers in Q1.
Vertical InP moat: InP laser manufacturing is the single most constrained component in the optical transceiver supply chain. AAOI has made lasers in-house for over 30 years — competitors face 21–24 month lead times for InP capacity additions; AAOI has <1 year of inventory on hand and is actively qualifying additional production equipment. This vertical integration is what customers specifically cite when selecting AAOI over Asian alternatives in the current supply environment.5 ELS/CPO opportunity: AAOI plans to expand Texas laser fabrication capacity +350% by end-2027 to serve External Laser Source (ELS) demand from co-packaged optics (CPO) deployments — a separate demand vector on top of the transceiver ramp.
The durability question is execution — whether the H2 2026 ramp and InP supply can track management's guidance — not thesis validity.
Structurally sound thesis with real Q1 data behind it. Durability grade limited by single-customer concentration and unproven scale.
Business Quality
B
Revenue trajectory is real and accelerating (Q2 guide $180–198M vs Q1 $151.1M). Cash position is solid at $449.4M after the $382.4M equity raise — runway for the Texas fab ramp is not in question. US-based manufacturing is a strategic asset for de-risking. However: still GAAP loss-making, gross margin 29.1% (adj. 29.2%) vs the 40%+ long-term target, and Q2 2026 is guided as only the first non-GAAP breakeven quarter.
CATV baseline stability: CATV generated $66.8M in Q1 (+3.6% YoY, +23.8% QoQ, near the top of guidance range). Management guides Q2 CATV of $75–80M and expects >$325M annually — this is a stable, recurring revenue floor that is often underappreciated relative to the 800G excitement. CATV funds ongoing operations while the Texas ramp compounds.
Insider selling at $29.6M over 90 days is the most visible concern — the people with the best view of the fab ramp trajectory are consistently reducing. Q1 slightly missed consensus ($151.1M vs $154.8M est) — a gap between guidance and delivery that needs to close in Q2 for confidence to build.
CATV baseline stability: CATV generated $66.8M in Q1 (+3.6% YoY, +23.8% QoQ, near the top of guidance range). Management guides Q2 CATV of $75–80M and expects >$325M annually — this is a stable, recurring revenue floor that is often underappreciated relative to the 800G excitement. CATV funds ongoing operations while the Texas ramp compounds.
Insider selling at $29.6M over 90 days is the most visible concern — the people with the best view of the fab ramp trajectory are consistently reducing. Q1 slightly missed consensus ($151.1M vs $154.8M est) — a gap between guidance and delivery that needs to close in Q2 for confidence to build.
Good trajectory, but too early to grade as A-tier. GM below 30%, still pre-GAAP profitability, insider sales ongoing.
Entry Price Discipline
C
At $157.55, the stock is up 1,027% in 52 weeks and within 18% of the 52-week high ($191.87). Entry zone of $120–140 requires a 12–24% pullback — achievable if Q2 misses consensus or if the macro softens in July/August. Analyst PT range is $54–$220 with a Rosenblatt buy at $220 and average around $151–190 depending on source; consensus has moved above current price post-Q1 (an improvement from the prior situation where PT was below price). Critical distinction: early-cycle holders entered around $29 — they have meaningful cost-basis cushion that absorbs volatility. New entrants at $157 are buying the thesis but not the cost-basis margin of safety. Every share up here is pricing in the H2 2026 ramp working. Q2 print on 6 Aug is the gate.
Not at entry zone yet. Wait for Q2 validation and a pullback to $120–140 before initiating.
Verdict
Watch. The 800G thesis is confirmed in volume and the Q1 data is real — $81.4M data centre revenue, FY26 guide above $1.1B, Q2 guide of $180–198M shows sequential acceleration. But new entry at $157 is buying an unproven Texas fab ramp at a price that reflects full optimism. The risk/reward only becomes favourable after: (1) Q2 print on 6 Aug validates that the ramp is on track (DC revenue should approach $110–130M, units shipped from Texas should be materially higher than Q1 exit of 100K/month), and (2) a pullback to $120–140 which implies modest disappointment or market softness. At entry zone, the margin of safety exists. At current price, it does not. Early holders at ~$29 are in a structurally different position — their cost basis provides cushion that no new entrant at $157 can replicate.
Entry zone: $120–140 only after Q2 print (6 Aug) validates H2 2026 ramp trajectory
📊 Opportunity Cost Check ▼
vs CSPX: CSPX at ~21× fwd P/E offers ~10% expected CAGR with no single-stock execution risk. AAOI at $157 is priced for full ramp execution — any Texas fab execution miss or Q2 consensus miss triggers a 30–50% drawdown. Risk-adjusted return favours CSPX over AAOI at current price. At entry zone $120–140, the calculus shifts materially: the downside is partially validated by the Q2 print, the GM trajectory is clearer, and the first non-GAAP profitability milestone provides a floor narrative.
vs COHR/LITE (held optical peers on watchlist): COHR and LITE are diversified optical plays with multiple customers and product lines. AAOI is a concentrated bet on 800G volume with a single hyperscaler — higher upside, higher downside than the peer set. AAOI is the highest-conviction 800G pure-play; it is not a defensive allocation.
vs cash (~19.5% NLV): The Q2 print on 6 Aug provides the natural deployment trigger. Using dry powder now at $157 misses the post-Q2 entry discipline. Patience here is the correct use of optionality — the same capital deployed at $130 post-confirmation is meaningfully better than at $157 pre-confirmation.
🔴 Thesis-Breakers ▼
- 01[Q2 2026 revenue] [misses $175M] [at Q2 print 6 Aug 2026] — Q2 guide midpoint is $189M; a miss below $175M signals that the Texas fab ramp is behind schedule and the H2 2026 acceleration to $1.1B+ annualised is not on track. Breaks the sequential acceleration thesis entirely.
- 02[GAAP gross margin] [fails to reach 33%] [by Q3 2026 print, ~Nov 2026] — management targets 35% by YE 2026; if Q3 GM is below 33% it signals the Texas fab yield ramp is not tracking toward the 40%+ target necessary for structural profitability. The entire long-term FCF model rests on hitting 40%+ GM.
- 03[NVDA or comparable hyperscaler announces integrated 800G switching] [before AAOI secures 2+ non-NVDA platform wins] [by end-2026] — single-customer concentration is the existential risk. If the primary hyperscaler internalises optical transceivers or qualifies a second vendor, AAOI loses its pricing power and volume guarantee simultaneously. Customer diversification by year-end is non-negotiable for a Hold upgrade.
⚠ Key Risks ▼
- 01Texas fab ramp execution — scaling from 100K to 650K units/month by end-2026 is the single most important and entirely unvalidated assumption; Q2 print on 6 Aug is the first real data point
- 02Single hyperscaler concentration — one customer is the majority of 800G volume; any pause, qualification delay, competitive design win, or internalisation decision collapses the H2 thesis instantly
- 03Q1 consensus miss and continued GM pressure — $151.1M vs $154.8M est; gross margin 29.1% vs target 35% YE26 — execution gap must close in Q2 or thesis credibility erodes
- 04Insider selling $29.6M in 90 days — consistent seller pattern from those closest to the ramp execution data; not a cluster (spread across multiple insiders, no single transaction >$50M), but the consistency is notable
- 05Stock up 1,027% in 52 weeks — at $157, any Q2 miss or guidance cut triggers a 30–50% drawdown from current levels; early-cycle holders have the cost-basis cushion to ride it; new entrants do not
📐 DCF Scenarios ▼
Discount rate: 13% (pre-profitability at GAAP level, high-growth, single-customer execution risk)
FCF base: ~$100M (FY26 estimate) — management guides >$140M non-GAAP operating income for FY26; after capex for Texas fab, FCF is estimated at ~$100M. This is the starting point of the ramp, not the destination.
Shares outstanding: ~80M (implied from ~$12.6B mkt cap ÷ $157.55, inclusive of equity raise)
| Scenario | Assumption | Implied Value |
|---|---|---|
| Bull | Texas fab ramp validates; FY27 revenue $2B+, GM 40%+; FCF grows 50% CAGR for 5 years from $100M base; 25× terminal | ~$140 |
| Base | Ramp partially validates; FY27 revenue $1.5B, GM reaches 36%; FCF 30% CAGR for 5 years; 20× terminal | ~$70 |
| Bear | Fab ramp fails to reach target; customer pauses orders; FCF stagnates at $30M; 15× terminal | ~$25 |
At $157, the market is pricing above the bull DCF of ~$140 — implying the market is pricing a faster ramp and/or a higher terminal multiple than the 50% CAGR / 25× scenario above. The asymmetry: bull case is $140 (−11% from current), bear case is $25 (−84%). This is the DCF argument for waiting for the Q2 validation before entry.
📅 Catalyst Timeline ▼
| Date | Event | Watch For |
|---|---|---|
| 6 Aug 2026 | Q2 2026 earnings — the key gate | Must see: (1) revenue ≥$180M (low end of guide), (2) DC revenue approaching $110–130M range, (3) gross margin improving toward 32%+, (4) units shipped from Texas tracking toward 200K+/month. A miss on any two of these is a thesis question mark. |
| Aug–Sep 2026 | Texas fab milestone: 200K+ units/month | Management has signalled intermediate capacity milestones. Any disclosed unit output data between earnings confirms ramp is on schedule. Silence is not bearish — absence of bad news. |
| Nov 2026 (est.) | Q3 2026 earnings | First quarter where H2 ramp should be substantially visible. Revenue must be on a trajectory toward $1.1B+ annualised run rate. Non-GAAP operating income target >$140M FY26 implies Q3+Q4 must carry meaningful non-GAAP profitability. GM should be at or above 33%. |
| End-2026 | Texas fab capacity target: 650K units/month | This is the big one. If achieved, AAOI has a revenue capacity envelope that implies $10B+ annually — a completely different valuation conversation. If partial (300–400K), it derisks while admitting execution conservatism. If well below target, thesis structurally weakens. |
💬 Analyst Commentary ▼
"Applied Optoelectronics is uniquely positioned as the only domestic 800G transceiver supplier shipping in hyperscaler volume — the Texas fab gives them supply-chain optionality that Chinese and Taiwanese competitors cannot match in the current geopolitical environment."
Rosenblatt Securities — Buy, PT $220 (raised from $140), May 2026
Consensus (5 analysts, as of 13 May 2026): Buy — 2 Strong Buy (40%), 2 Buy (40%), 1 Hold (20%). Average PT range $151–190 (eToro consensus $151.30; Rosenblatt high $220; bear $54). Small analyst coverage universe reflects AAOI's still-emerging institutional profile — consensus has improved materially post-Q1 when PT moved above current price for the first time.
"My bull case for AAOI is that hyperscaler demand for high-speed optics is intense, and has outpaced the industry's ability to make them. AAOI offers vertical integration on lasers and is publicly committing to a significant step-up in revenue come 2H with over 141% growth this year. However, any small slip in InP capacity or equipment delivery could trigger an adjustment to expectations."
Beth Kindig / IO Fund · Applied Optoelectronics Q1: Management Guides to 141% YoY Growth, Execution Comes Next · 13 May 20265
No tracked commentary from Serenity or Dylan Patel on AAOI as of 14 May 2026.
Sources:
1 AAOI Q1 2026 earnings press release (investors.ao-inc.com, 7 May 2026)
2 AAOI Q1 2026 earnings call transcript (Motley Fool, 7 May 2026)
3 AAOI Q1 2026 8-K (SEC EDGAR)
4 Rosenblatt Securities analyst note, Buy PT $220, May 2026 · Benzinga / eToro analyst consensus, 13 May 2026
5 IO Fund (Beth Kindig / Royston Roche) — "Applied Optoelectronics Q1: Management Guides to 141% YoY Growth, Execution Comes Next", 13 May 2026 (premium)
1 AAOI Q1 2026 earnings press release (investors.ao-inc.com, 7 May 2026)
2 AAOI Q1 2026 earnings call transcript (Motley Fool, 7 May 2026)
3 AAOI Q1 2026 8-K (SEC EDGAR)
4 Rosenblatt Securities analyst note, Buy PT $220, May 2026 · Benzinga / eToro analyst consensus, 13 May 2026
5 IO Fund (Beth Kindig / Royston Roche) — "Applied Optoelectronics Q1: Management Guides to 141% YoY Growth, Execution Comes Next", 13 May 2026 (premium)